Biotricity, Inc. (BTCY)
USD 0.29
(-5.83%)
USD 0.29
(-5.83%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.69 Million | -13.54 Million | -15.16 Million | -11.08 Million | -7.86 Million | -5.22 Million |
| Net Income | -14.09 Million | -18.65 Million | -29.13 Million | -15.49 Million | -11.06 Million | -8.59 Million |
| Depreciation & Amortization | 371.85 Thousand | 5953.00 | 2308.00 | 347.11 Thousand | 148.76 Thousand | - |
| Deferred income taxes | - | 483.87 Thousand | 683.55 Thousand | -347.11 Thousand | -148.76 Thousand | - |
| Stock-based compensation | 1.02 Million | 647.63 Thousand | 913.61 Thousand | 790.53 Thousand | 2.4 Million | 1.45 Million |
| Change in working capital | 3.68 Million | 2.3 Million | -117.58 Thousand | -627.9 Thousand | -286.5 Thousand | 307.09 Thousand |
| Other non-cash items | 658.97 Thousand | 1.66 Million | 12.48 Million | 4.24 Million | 1.08 Million | 1.61 Million |
| Investing Cash Flow | - | - | -29.76 Thousand | - | - | - |
| Investments in PPE | - | - | -29.76 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 6.74 Million | 2 Million | 25.16 Million | 12.2 Million | 8.87 Million | 4.55 Million |
| Debt repayment | -3.81 Million | -3.83 Million | -1.66 Million | -408.08 Thousand | -1.2 Million | -867.69 Thousand |
| Dividends payments | -18.01 Thousand | -946.78 Thousand | -966.11 Thousand | -602.96 Thousand | -180 Thousand | - |
| Common Stock Repurchased | - | -895.55 Thousand | -230 Thousand | - | - | - |
| Common Stock Issuance | 2.94 Million | 12.5 Thousand | 14.79 Million | 267.94 Thousand | 28.56 Thousand | 3.63 Million |
| Other Financing Activities | 6.75 Million | 3.84 Million | 26.45 Million | 13.21 Million | 9.03 Million | 918.53 Thousand |
| Accounts receivables | -298.24 Thousand | 686.19 Thousand | -435.48 Thousand | -1.03 Million | -326.2 Thousand | -208.09 Thousand |
| Accounts payables | 3.27 Million | 3.34 Million | 948.99 Thousand | 752.35 Thousand | 75.73 Thousand | 652.69 Thousand |
| Inventory | 457.6 Thousand | -1.49 Million | -570.43 Thousand | -186.77 Thousand | -61.11 Thousand | -24.6 Thousand |
| Other working capital | 252.14 Thousand | -224.81 Thousand | -60.66 Thousand | -156.59 Thousand | 25.08 Thousand | 539.79 Thousand |
| Cash at beginning of period | 570.46 Thousand | 12.06 Million | 2.2 Million | 949.84 Thousand | 63.64 Thousand | 843.64 Thousand |
| Cash at end of period | 786.06 Thousand | 570.46 Thousand | 12.06 Million | 2.2 Million | 949.84 Thousand | 63.64 Thousand |
| Capital Expenditure | - | - | -29.76 Thousand | - | - | - |
| Effect of forex changes on cash | 167.82 Thousand | 49.86 Thousand | -109.71 Thousand | 129.06 Thousand | -130.18 Thousand | -115.69 Thousand |
| Net cash flow / Change in cash | 215.6 Thousand | -11.49 Million | 9.86 Million | 1.25 Million | 886.2 Thousand | -779.99 Thousand |
| Free Cash Flow | -6.69 Million | -13.54 Million | -15.19 Million | -11.08 Million | -7.86 Million | -5.22 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -14.09 Million | -4.18 Million | -2.8 Million | -3.69 Million | -3.41 Million | -4.67 Million |
| Depreciation & Amortization | 371.85 Thousand | 96.03 Thousand | 94.52 Thousand | 1488.00 | 1489.00 | 1488.00 |
| Deferred income taxes | - | -33.12 Thousand | 69.76 Thousand | 71.26 Thousand | -107.9 Thousand | -218.62 Thousand |
| Stock-based compensation | 1.02 Million | 481.27 Thousand | 170.14 Thousand | 163.33 Thousand | 211.18 Thousand | 281.97 Thousand |
| Change in working capital | 3.68 Million | 2.02 Million | 444.27 Thousand | 377.78 Thousand | 830.97 Thousand | 1.57 Million |
| Other non-cash items | 658.97 Thousand | -1.05 Million | 723.42 Thousand | 686.93 Thousand | 645.02 Thousand | 1.14 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 6.74 Million | 1.78 Million | 194.54 Thousand | 3.42 Million | 1.32 Million | 1.99 Million |
| Debt repayment | -3.81 Million | -863.5 Thousand | -200.59 Thousand | -1.41 Million | -1.33 Million | -2 Million |
| Dividends payments | -18.01 Thousand | - | -6049.00 | -5918.00 | -6049.00 | -6049.00 |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.94 Million | 925 Thousand | - | 2.01 Million | - | - |
| Other Financing Activities | 6.75 Million | 6.75 Million | 200.59 Thousand | 3.43 Million | 1.33 Million | 2 Million |
| Accounts receivables | -298.24 Thousand | 79.33 Thousand | 33.86 Thousand | -80.43 Thousand | -331 Thousand | 726.99 Thousand |
| Accounts payables | 3.27 Million | 1.89 Million | 315.8 Thousand | -9872.00 | 1.07 Million | 1.41 Million |
| Inventory | 457.6 Thousand | 169.5 Thousand | 79.28 Thousand | 87.36 Thousand | 121.44 Thousand | -405.11 Thousand |
| Other working capital | 252.14 Thousand | -111.56 Thousand | 15.31 Thousand | 380.72 Thousand | -32.33 Thousand | -152.94 Thousand |
| Cash at beginning of period | 570.46 Thousand | 85.09 Thousand | 1.19 Million | 51.43 Thousand | 570.46 Thousand | 451.42 Thousand |
| Cash at end of period | 786.06 Thousand | 786.06 Thousand | 85.09 Thousand | 1.19 Million | 51.43 Thousand | 570.46 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 167.82 Thousand | 78.25 Thousand | -3212.00 | 108.83 Thousand | -16.05 Thousand | -177.00 |
| Net cash flow / Change in cash | 215.6 Thousand | 700.96 Thousand | -1.11 Million | 1.14 Million | -519.02 Thousand | 119.03 Thousand |
| Free Cash Flow | -6.69 Million | -1.16 Million | -1.3 Million | -2.39 Million | -1.83 Million | -1.87 Million |
NEOEN
ASGR
AFEL
0874
BNB
002038